Related Experiment Videos
Prognostic characteristics in breast cancers after hormone replacement therapy
C Magnusson1, L Holmberg, T Nordén
1Department of Cancer Epidemiology, University Hospital, Uppsala, Sweden.
Breast Cancer Research and Treatment
|January 1, 1996
Summary
Hormone replacement therapy (HRT) may be linked to more favorable breast tumor characteristics, particularly with combined estrogen-progestin regimens. This suggests a potentially less aggressive tumor behavior in women using HRT.
Area of Science:
- Oncology
- Endocrinology
- Pathology
Background:
- Hormone replacement therapy (HRT) is widely used by postmenopausal women.
- The impact of HRT on breast cancer biology and prognosis requires further investigation.
Purpose of the Study:
- To investigate the influence of HRT on breast tumor characteristics and patient survival.
- To compare prognostic features of breast cancers in women with and without HRT use.
Main Methods:
- Retrospective cohort study comparing 121 women on HRT with 1468 women not on HRT.
- Analysis of tumor size, lymph node status, tumor differentiation, and ploidy in relation to HRT use.
- Statistical analysis including odds ratios (OR) and confidence intervals (CI), with adjustments for lead time bias.
Main Results:
- Women on HRT showed a reduced risk of larger tumors (>20 mm) and lymph node metastasis (OR = 0.7).
- Combined estradiol-progestin regimens were associated with the most significant risk reductions and less poorly differentiated tumors.
- HRT, especially conjugated estrogens/estradiols, indicated a decreased risk of aneuploid tumors. Oestriol showed less favorable results.
Conclusions:
- Breast cancers in women using HRT, particularly combined regimens, exhibit more favorable biological features.
- Findings suggest potentially less aggressive tumor behavior or earlier detection in HRT users.
- No significant association between HRT and breast cancer survival was observed in this study.